ncRNA basic information
ncRNA ID:
NONHSAT055585.2
ncRNA Database:
NONCODE
ncRNA Name:
RP1-193H18.2
ncRNA Type:
lncRNA
ncRNA Expression:
up-regulated
ncRNA Method:
qPCR
ncRNA Target Gene:
NA
ncRNA Pathway:
p53 signaling pathway
Evidence (ncRNA-drug):
validated
drug basic information
Drug ID:
DB00515 (APRD00359)
Drug Name:
Cisplatin
Drug Method:
Reannotation and identification of differentially expressed lncRNAs were performed using the microarray data set GSE38122 in the Gene Expression Omnibus database. The role of lncrna in HepG2 cells was detected using qPCR, cell cycle analysis, Immunofluorescence and microscopic analysis, etc.
Drug Response:
sensitive
Cancer basic information
Cancer:
hepatocellular carcinoma
Tissue/Cell:
cell line (HepG2)
Other information
Title:
Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway.
Journal:
Oncol Lett
Published:
2016
PubMed ID:
28105167